Anti rps19

Manufactured by Fortis Life Sciences

Anti-rpS19 is a laboratory product that targets the ribosomal protein S19 (rpS19). It is used for research purposes to investigate the role and function of rpS19 in various biological processes.

Automatically generated - may contain errors

Lab products found in correlation

5 protocols using anti rps19

Comprehensive Protein Expression Analysis Using Western Blotting

Check if the same lab product or an alternative is used in the 5 most similar protocols

Western blot analysis was performed using the following antibodies: anti-eIF3a (Novus NBP1-18891); anti-eIF3b (Bethyl A301-761A); anti-eIF3c (Bethyl A300-376A); anti-eIF3d (Bethyl A301-758A); anti-eIF3e (Bethyl A302-985A); anti-eIF3f (Bethyl A303-005A); anti-eIF3g antibody (Bethyl A301-757A); anti-eIF3h antibody (Bethyl A301-754A); anti-eIF3i (Biolegend 646701); anti-eIF3k (Novus NB100-93304); anti-eIF3l antibody (Genetex GTX120119); anti-eIF3m (Novus NBP1-56654); anti-rpS19 (Bethyl A304-002A); anti-eIF4G1 (Bethyl A301-775A); anti-c-Jun (Bethyl A302-959A); anti-BTG1 (Abcam ab151740). anti-GAPDH (Bethyl A300-640A); anti-HSP90 (BD 610418).

Lee A.S., Kranzusch P.J, & Cate J.H. (2015). eIF3 targets cell proliferation mRNAs for translational activation or repression. Nature, 522(7554), 111-114.

+ Open protocol

+ Expand

Comprehensive Protein Expression Analysis Using Western Blotting

Check if the same lab product or an alternative is used in the 5 most similar protocols

Lee A.S., Kranzusch P.J, & Cate J.H. (2015). eIF3 targets cell proliferation mRNAs for translational activation or repression. Nature, 522(7554), 111-114.

+ Open protocol

+ Expand

Western Blot Antibody Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols

Western blot analyses were performed using the following antibodies: anti-eIF3d (Bethyl A301-758A), anti-eIF4A1 (Cell Signaling 2490), anti-eIF4G1 (Cell Signaling 2858), anti-rpS19 (Bethyl A304-002A), anti-eIF4E (Bethyl A301-154A), anti-rpLP0 (Bethyl A302-882A), anti-HA epitope tag (Pierce 26183), anti-c-Jun (Cell Signaling 9165), anti-Hsp90 (BD Biosciences 610418), and anti-4EBP1 (Cell Signaling 9644).

Lee A.S., Kranzusch P.J., Doudna J.A, & Cate J.H. (2016). eIF3d is an mRNA cap-binding protein required for specialized translation initiation. Nature, 536(7614), 96-99.

+ Open protocol

+ Expand

Western Blot Antibody Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols

Lee A.S., Kranzusch P.J., Doudna J.A, & Cate J.H. (2016). eIF3d is an mRNA cap-binding protein required for specialized translation initiation. Nature, 536(7614), 96-99.

+ Open protocol

+ Expand

Immunoblot Antibody Dilutions for Protein Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols

Immunoblot studies were performed using the following antibodies at 1:1000 dilution: anti-DAP5 (BD Biosciences 610742); anti-eIF3d (Bethyl A301-758A); anti-eIF4A1 (Cell Signaling 2490); anti-eIF4G1 (Cell Signaling 2858); anti-rpS19 (Bethyl A304-002A); anti-eIF4E (Bethyl A301-154A); anti-HA epitope tag (Abcam 18181); anti-c-Jun (Cell Signaling 9165); anti-CDK12 (Cell Signaling 11973); anti-MMP1 (Abcam 137332); anti-GAPDH (Cell Signaling 2118S); anti-4E-BP1 (Cell Signaling 9644); anti-Lumin A (Abcam 226189); anti-AUF1 (EMD Millipore 07260); anti FXR1 (Cell Signaling 12295); anti FXR2 (Cell Signaling 7098); and anti-PABP (Cell Signaling 4992). The following antibodies were used at 1:500 dilution: anti-ETS1 (Abcam 26096); anti-OSMR (Abcam 210771); anti-EGFR (Cell Signaling 4257); anti-SERPINE2 (Abcam 75348); anti-ITGV (Abcam 124968); and anti-p53-BP1 (Abcam 21083).

de la Parra C., Ernlund A., Alard A., Ruggles K., Ueberheide B, & Schneider R.J. (2018). A widespread alternate form of cap-dependent mRNA translation initiation. Nature Communications, 9, 3068.

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!